Press "Enter" to skip to content

Proton Pump Inhibitors Market Outlook 2019 | Shows Industry Overview, Size, Share, Remarkable Growth Factors, Types, and Applications Forecast to 2024

Proton

The “Proton Pump Inhibitors Market” research report 2019 delivers comprehensive information about the market ranging from the establishment to the predictable growth trend. Proton Pump Inhibitors market report provides brief analytical data of the market contenders globally using advanced methodological approaches, such as SWOT analysis, production chain, cost, sales margin, financial details, recent developments. Proton Pump Inhibitors market report also offers market competitors that includes detailed company profiles along with company product specifications.

Market Overview:

  • The major factors for the growth of the proton pump inhibitors market include the increasing prevalence of gastroesophageal reflux disease (GERD) and the rising acceptance of novel drug delivery systems.
  • Gastroesophageal reflux disease is a chronic condition, where the stomach content comes back up into the esophagus resulting in either symptoms or complications. The most frequently reported symptoms of GERD are heartburn, a burning discomfort that begins behind the breastbone and radiates to the neck and throat, and acid regurgitation, which is characterized as a bitter, sour-tasting fluid.
  • In addition to the increase in prevalence, people with risk factors, such as obesity, tobacco use, and others, are also increasing in almost every part of the world. Obesity, which is the major risk factor of GERD, is increasing rapidly in developed countries, such as the United States, the United Kingdom, and others. The increasing prevalence of GERD, along with the growing risk factor population, is likely to lead to the growth in the demand for proton pump inhibitors, which in turn, will drive the market. Also, the increasing shift from prescription to OTC drugs is driving the proton pump inhibitors market.

    Get a Sample Copy of the Report – https://www.industryresearch.co/enquiry/request-sample/13999751

    In Proton Pump Inhibitors Market Report, Following Companies Are Covered:

  • AstraZeneca
  • Bayer AG
  • Cadila Pharmaceuticals
  • Eli Lilly and Company
  • Eisai Inc.
  • GlaxoSmithKline PLC
  • Johnson & Johnson
  • Pfizer Inc.
  • Santarus Inc.
  • Takeda Pharmaceuticals

    Proton Pump Inhibitors Market 2019 report will help the industry aspirants in arranging their strategies. The measurements offered in this report will be an exact and helpful manual to shape the business development. Additionally, will Provide historical data along with a future forecast and detailed analysis and also expected opportunities.

    Scope of the Report:

  • As per the , proton pump inhibitors (PPIs) are a group of drugs, whose main action is the long-lasting reduction of gastric acid production. They are the most potent inhibitors of acid secretion available. The market studied is further segmented on the basis of drug type and geography. The drug type segmentation includes OTC and prescription drugs.

    Reasons for Buying Proton Pump Inhibitors Market Report:

    • This report provides pin-point analysis for changing competitive dynamics
    • It provides a forward looking perspective on different factors driving or restraining market growth
    • It provides a five-year forecast assessed on the basis of how the market is predicted to grow
    • It helps in understanding the key product segments and their future
    • It provides pin point analysis of changing competition dynamics and keeps you ahead of competitors
    • It helps in making informed business decisions by having complete insights of market and by making in-depth analysis of market segments

    For More Information or Query or Customization Before Buying, Visit at – https://www.industryresearch.co/enquiry/pre-order-enquiry/13999751

    Key Market Trends:

    Esomeprazole is Expected to Account for the Largest Market Share in Drug Type

    Nexium is one among the leading revenue generating drugs globally, and it is used to treat the symptoms of GERD, heartburn, and other disorders involving excessive stomach acids. The drug was being sold as a prescriptive drug till before 28th March 2014, the date when FDA approved it as an OTC drug. The shift from being a prescription-only drug to being sold as an over-the-counter (OTC) drug is likely to be a major driving force for the sales of the drug in the near future. There are several benefits associated with OTC drugs, such as low price, enhanced accessibility, and no regular monitoring. As OTC drugs are sold without any prescription, the consumer need not go to any doctor for a prescription, which reduces the overall cost, and hence these drugs have the potential to increase their adoption rate. Accessibility is another vital factor for the consumption of any medicine, and better accessibility may definitely result in more revenue. However, OTC drugs have some disadvantages as well. As they can be purchased without any prescription, anyone can buy as many as they want and leave the scope for their overuse.

    Additionally, there are several minor side effects, such as nausea, headaches, dry mouth, diarrhea, allergic reaction, and others, as well as some major side effects, such as kidney disease, dementia, and others associated with its use, which can affect the adoption rate, and hence can be the restraining factors for the growth of the market.

    North America Accounted for the Largest Share in the Global Market

    North America holds a major share in the proton pump inhibitors market and is expected to show a similar trend over the forecast period, without significant fluctuations. There is a rising prevalence of GERD in the United States, Canada, and Mexico. Furthermore, GERD affects up to 20% of adults in the United States, therefore making the disease an important concern. Proton pump inhibitors are the widely prescribed drugs, and increased PPI use has been observed in the US ambulatory settings. Furthermore, many firms are expected to spend heavily on promoting their brands. The widespread use of these has recently gained attention from the American Board of Internal Medicine’s campaign to promote the appropriate use of PPIs.

    The Research Document Will Answer Following Questions Such as:

    • What are the cutting-edge technologies responsible for driving the growth of the market?
    • What are the main applications of the market? What are the growth prospects to the market applications into the market?
    • At what stage of development are the key market products?
    • What are the shortcomings that has to face to become commercially viable? Is their growth and commercialization dependent on cost declines or technological/application breakthroughs?
    • What is the outlook for the industry?
    • What difference does performance characteristics of Proton Pump Inhibitors create from those of established entities?

    Purchase this Report (Price 4250 USD for single user license) – https://www.industryresearch.co/purchase/13999751

    Detailed TOC of Proton Pump Inhibitors Market Report 2019-2024:

    1 INTRODUCTION
    1.1 Study Deliverables
    1.2 Study Assumptions
    1.3 Scope of the Study

    2 RESEARCH METHODOLOGY

    3 EXECUTIVE SUMMARY

    4 MARKET DYNAMICS
    4.1 Market Overview
    4.2 Market Drivers
    4.2.1 Increasing Prevalence of Gastroesophageal Reflux Disease (GERD)
    4.2.2 Rising Acceptance of Novel Drug Delivery Systems
    4.3 Market Restraints
    4.3.1 Increasing Use of Generic Products
    4.4 Porter’s Five Forces Analysis
    4.4.1 Threat of New Entrants
    4.4.2 Bargaining Power of Buyers/Consumers
    4.4.3 Bargaining Power of Suppliers
    4.4.4 Threat of Substitute Products
    4.4.5 Intensity of Competitive Rivalry

    5 MARKET SEGMENTATION
    5.1 By Drug Type
    5.1.1 OTC (Over-the-Counter) Drugs
    5.1.1.1 Omeprazole
    5.1.1.2 Lansoprazole
    5.1.1.3 Esomeprazole
    5.1.1.4 Other OTC Drugs
    5.1.2 Prescription Drugs
    5.1.2.1 Rabeprazole
    5.1.2.2 Dexlansoprazole
    5.1.2.3 Pantoprazole
    5.1.2.4 Other Prescription Drugs
    5.2 Geography
    5.2.1 North America
    5.2.1.1 US
    5.2.1.2 Canada
    5.2.1.3 Mexico
    5.2.2 Europe
    5.2.2.1 Germany
    5.2.2.2 UK
    5.2.2.3 France
    5.2.2.4 Italy
    5.2.2.5 Spain
    5.2.2.6 Rest of Europe
    5.2.3 Asia-Pacific
    5.2.3.1 China
    5.2.3.2 Japan
    5.2.3.3 India
    5.2.3.4 Australia
    5.2.3.5 South Korea
    5.2.3.6 Rest of Asia-Pacific
    5.2.4 Middle East & Africa
    5.2.4.1 GCC
    5.2.4.2 South Africa
    5.2.4.3 Rest of Middle East & Africa
    5.2.5 South America
    5.2.5.1 Brazil
    5.2.5.2 Argentina
    5.2.5.3 Rest of South America

    6 COMPETITIVE LANDSCAPE
    6.1 Company Profiles
    6.1.1 AstraZeneca
    6.1.2 Bayer AG
    6.1.3 Cadila Pharmaceuticals
    6.1.4 Eli Lilly and Company
    6.1.5 Eisai Inc.
    6.1.6 GlaxoSmithKline PLC
    6.1.7 Johnson & Johnson
    6.1.8 Pfizer Inc.
    6.1.9 Santarus Inc.
    6.1.10 Takeda Pharmaceuticals

    7 MARKET OPPORTUNITIES AND FUTURE TRENDS

     

    Contact Us:

    Name: Ajay More

    Phone: US +14242530807/ UK +44 20 3239 8187

    Email: [email protected]

    Our Other Reports:

    Sedatives Market 2019 | Emerging Technologies by Size and Share, Key Players Analysis, Sales Revenue, Growth Status, Opportunity Assessment and Business Expansion Plans 2024

    Hematology Analyzer Industry 2019 Global Market Growth, Trends, Revenue, Key Suppliers, Demands and Detailed Insights on Upcoming Trends 2024

    Calcium Bentonite Industry 2019 | Global Market Size, Share, Revenue, Emerging Trends of Top Companies, and Development Forecast to 2023

    CDN Market 2018 Global Industry Size, Future Trends, Growth Key Factors, Demand, Business Share, Sales & Income, Manufacture Players, Application, Scope, and Opportunities Analysis by Outlook – 2023

  • Be First to Comment

    Leave a Reply

    Your email address will not be published. Required fields are marked *